Open access · CC-BY
via OpenAlex
Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis
Ram Hari Dahal, Shukho Kim, Yu Kyung Kim, Eun Soo Kim, Jungmin Kim
Frontiers in Microbiology · 2023 · ▲ 88 citations
Abstract
The collection of whole microbial communities (bacteria, archaea, fungi, and viruses) together constitutes the gut microbiome. Diet, age, stress, host genetics, and diseases cause increases or decreases in the relative abundance and diversity of bacterial species (dysbiosis). We aimed to investigate the gut microbial composition at different taxonomic levels of healthy controls (HCs) with active Crohn’s disease (CD), ulcerative colitis (UC), and ischemic colitis (IC) using culture- and non-culture-based approaches and identify biomarkers to discriminate CD, UC, or IC. We determined the specific changes in the gut microbial profile using culture-independent (16S rRNA gene amplicon sequencing) as well as culture-based (culturomic) approaches. Biomarkers were validated using quantitative Real-Time PCR (qPCR). In both methods, bacterial diversity and species richness decreased in disease-associated conditions compared with that in HCs. Highly reduced abundance of Faecalibacterium prausnitzii and Prevotella sp. and an increased abundance of potentially pathogenic bacteria such as Enterococcus faecium , Enterococcus faecalis , and Escherichia coli in all CD, UC, or IC conditions were observed. We noted a high abundance of Latilactobacillus sakei in CD patients; Ligilactobacillus ruminis in UC patients; and Enterococcus faecium , Escherichia coli , and Enterococcus faecalis in IC patients. Highly reduced abundance of Faecalibacterium prausnitzii in all cases, and increased abundance of Latilactobacillus sakei and Enterococcus faecium in CD, Ligilactobacillus ruminis and Enterococcus faecium in UC, and Enterococcus faecium , Escherichia coli , and Enterococcus faecalis in IC could be biomarkers for CD, UC, and IC, respectively. These biomarkers may help in IBD (CD or UC) and IC diagnosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmicb.2023.1174832
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Dahal, R.H., Kim, S., Kim, Y.K., Kim, E.S., & Kim, J. (2023). Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. <em>Frontiers in Microbiology</em>. https://doi.org/10.3389/fmicb.2023.1174832
Vancouver
Dahal RH, Kim S, Kim YK, Kim ES, Kim J. Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. Frontiers in Microbiology. 2023. doi:10.3389/fmicb.2023.1174832.
BibTeX
@article{ram2023Insigh,
title = {Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis},
author = {Ram Hari Dahal and Shukho Kim and Yu Kyung Kim and Eun Soo Kim and Jungmin Kim},
journal = {Frontiers in Microbiology},
year = {2023},
doi = {10.3389/fmicb.2023.1174832},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Microbiome 2016
Open access · CC-BY
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
Frontiers in Cellular and Infection Microbiology 2019
Open access · CC-BY
Dysbiosis of the Gut Microbiome in Lung Cancer
Egyptian Journal of Chest Diseases and Tuberculosis 2013
Open access · CC-BY
Role of adiponectin and other inflammatory biomarkers in COPD patients
Scientific Reports 2016
Open access · CC-BY
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Frontiers in Aging Neuroscience 2014
Open access · CC-BY
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
Frontiers in aging neuroscience 2026
Open access · OA